Rubius Therapeutics hauls in $100 mln
Cambridge, Massachusetts-based Rubius Therapeutics, a creator of cellular therapies, has closed $100 million in funding. The investors in this round were not named.
1 March 2018•1 min read
Cambridge, Massachusetts-based Rubius Therapeutics, a creator of cellular therapies, has closed $100 million in funding. The investors in this round were not named.
